{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:12:43Z","timestamp":1792692763074,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":575,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41385-020-0287-5","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T10:02:34Z","timestamp":1587463354000},"page":"566-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Seasonal and pandemic influenza: 100 years of progress, still much to learn"],"prefix":"10.1016","volume":"13","author":[{"given":"Jake","family":"Dunning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-2555","authenticated-orcid":false,"given":"Peter J.M.","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41385-020-0287-5_bib1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ni1530","article-title":"Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic","volume":"8","author":"Ahmed","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib2","unstructured":"WHO. Virology of Influenza. [cited 28 Oct 2019] http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/data-and-statistics\/virology-of-human-influenza."},{"key":"10.1038\/s41385-020-0287-5_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"key":"10.1038\/s41385-020-0287-5_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-042617-053309","article-title":"RIG-I and other RNA sensors in antiviral immunity","volume":"36","author":"Chow","year":"2018","journal-title":"Annu Rev. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41590-018-0111-5","article-title":"Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza","volume":"19","author":"Dunning","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/CS20160484","article-title":"Contribution of innate immune cells to pathogenesis of severe influenza virus infection","volume":"131","author":"Cole","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1038\/s41385-020-0287-5_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00281-016-0558-0","article-title":"The host immune response in respiratory virus infection: balancing virus clearance and immunopathology","volume":"38","author":"Newton","year":"2016","journal-title":"Semin Immunopathol."},{"key":"10.1038\/s41385-020-0287-5_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2016.01.016","article-title":"Human influenza viruses and CD8(+) T cell responses","volume":"16","author":"Grant","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1038\/s41385-020-0287-5_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.it.2014.06.004","article-title":"T cell mediated immunity to influenza: mechanisms of viral control","volume":"35","author":"La Gruta","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib10","article-title":"Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity","volume":"1","author":"Koutsakos","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1038\/s41385-020-0287-5_bib11","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"CI Insight"},{"key":"10.1038\/s41385-020-0287-5_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coi.2013.07.005","article-title":"Correlates of protection against influenza infection in humans\u2013on the path to a universal vaccine?","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/rmv.1713","article-title":"Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines","volume":"22","author":"Marcelin","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1038\/s41385-020-0287-5_bib14","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1473-3099(18)30359-1","article-title":"Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself","volume":"18","author":"Oxford","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2012.194139","article-title":"Bacterial coinfection in influenza: a grand rounds review","volume":"309","author":"Chertow","year":"2013","journal-title":"JAMA"},{"key":"10.1038\/s41385-020-0287-5_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.2008-1336","article-title":"Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection","volume":"122","author":"Finelli","year":"2008","journal-title":"Pediatrics"},{"key":"10.1038\/s41385-020-0287-5_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coi.2015.02.002","article-title":"The immunology of influenza virus-associated bacterial pneumonia","volume":"34","author":"Robinson","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.immuni.2017.06.021","article-title":"Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections","volume":"47","author":"Roquilly","year":"2017","journal-title":"Immunity"},{"key":"10.1038\/s41385-020-0287-5_bib20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41590-018-0231-y","article-title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus","volume":"19","author":"Jochems","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"10.1038\/s41385-020-0287-5_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00949-2019","article-title":"Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza","volume":"54","author":"Jha","year":"2019","journal-title":"Eur. Respir. J"},{"key":"10.1038\/s41385-020-0287-5_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol Rev."},{"key":"10.1038\/s41385-020-0287-5_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/287301a0","article-title":"Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus","volume":"287","author":"Gething","year":"1980","journal-title":"Nature"},{"key":"10.1038\/s41385-020-0287-5_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMp038238","article-title":"Influenza vaccine\u2013outmaneuvering antigenic shift and drift","volume":"350","author":"Treanor","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-020-0287-5_bib26","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(10)62204-0","article-title":"Eyewitness accounts of the 1510 influenza pandemic in Europe","volume":"376","author":"Morens","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/s41385-020-0287-5_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/mi.2010.34","article-title":"Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak","volume":"3","author":"Openshaw","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib29","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMra1000449","article-title":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection","volume":"362","author":"Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41385-020-0287-5_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/thoraxjnl-2011-200266","article-title":"Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A\/H1N1 pandemic 2009-2010 in the UK","volume":"67","author":"Myles","year":"2012","journal-title":"Thorax"},{"key":"10.1038\/s41385-020-0287-5_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.24946","article-title":"The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults","volume":"90","author":"Segaloff","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1038\/s41385-020-0287-5_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fcimb.2018.00343","article-title":"Back to the future: lessons learned from the 1918 influenza pandemic","volume":"8","author":"Short","year":"2018","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1038\/s41385-020-0287-5_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep03058","article-title":"Adaptation of novel H7N9 influenza A virus to human receptors","volume":"3","author":"Dortmans","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1038\/s41385-020-0287-5_bib34","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMp1304661","article-title":"Global concerns regarding novel influenza A (H7N9) virus infections","volume":"368","author":"Uyeki","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41385-020-0287-5_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.it.2009.09.004","article-title":"Innate immune responses to influenza A H5N1: friend or foe?","volume":"30","author":"Peiris","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib36","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1164\/rccm.201311-2071OC","article-title":"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection","volume":"189","author":"Guihot","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1038\/s41385-020-0287-5_bib37","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.16.17-00454","article-title":"Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013","volume":"23","author":"Cassini","year":"2018","journal-title":"Euro. Surveill"},{"key":"10.1038\/s41385-020-0287-5_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur. Respir. J"},{"key":"10.1038\/s41385-020-0287-5_bib39","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41385-020-0287-5_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(09)70233-6","article-title":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review","volume":"9","author":"Warren-Gash","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1038\/s41385-020-0287-5_bib42","doi-asserted-by":"crossref","first-page":"e0193263","DOI":"10.1371\/journal.pone.0193263","article-title":"Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016","volume":"13","author":"Newman","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1038\/s41385-020-0287-5_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(14)70034-7","article-title":"Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study","volume":"2","author":"Hayward","year":"2014","journal-title":"Lancet Respir. Med"},{"key":"10.1038\/s41385-020-0287-5_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1038\/s41385-020-0287-5_bib45","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMcp1512870","article-title":"CLINICAL PRACTICE. Influenza vaccination","volume":"375","author":"Treanor","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1038\/s41385-020-0287-5_bib46","unstructured":"Committee On Infectious, D. Recommendations for prevention and control of influenza in children, 2018\u20132019. Pediatrics142 (2018)."},{"key":"10.1038\/s41385-020-0287-5_bib47","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/S1473-3099(17)30360-2","article-title":"Urgent challenges in implementing live attenuated influenza vaccine","volume":"18","author":"Singanayagam","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib48","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1016\/j.vaccine.2011.07.128","article-title":"Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok(R)) against influenza in healthy adults: a randomized, placebo-controlled trial","volume":"29","author":"Treanor","year":"2011","journal-title":"Vaccine"},{"key":"10.1038\/s41385-020-0287-5_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00114-18","article-title":"Activation and induction of antigen-specific T follicular helper cells play a critical role in live-attenuated influenza vaccine-induced human mucosal anti-influenza antibody response","volume":"92","author":"Aljurayyan","year":"2018","journal-title":"J. Virol"},{"key":"10.1038\/s41385-020-0287-5_bib50","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","article-title":"The role of nasal IgA in children vaccinated with live attenuated influenza vaccine","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1038\/s41385-020-0287-5_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ccm.2016.11.009","article-title":"Vaccines in the prevention of viral pneumonia","volume":"38","author":"Fraser","year":"2017","journal-title":"Clin. Chest Med"},{"key":"10.1038\/s41385-020-0287-5_bib52","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1038\/s41385-020-0287-5_bib53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev-immunol-032414-112315","article-title":"Exploiting Mucosal Immunity for Antiviral Vaccines","volume":"34","author":"Iwasaki","year":"2016","journal-title":"Annu Rev. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.7326\/0003-4819-39-2-203","article-title":"Influenza: the new acquayantance","volume":"39","author":"Francis","year":"1953","journal-title":"Ann. Intern. Med."},{"key":"10.1038\/s41385-020-0287-5_bib55","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02281-16","article-title":"Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the Elderly by ELISA and enzyme inhibition: evidence for original antigenic Sin","volume":"8","author":"Rajendran","year":"2017","journal-title":"mBio"},{"key":"10.1038\/s41385-020-0287-5_bib58","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"key":"10.1038\/s41385-020-0287-5_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","article-title":"From original antigenic sin to the universal influenza virus vaccine","volume":"39","author":"Henry","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing seasonal influenza\u2014the need for a universal influenza vaccine","volume":"378","author":"Paules","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41385-020-0287-5_bib61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1586\/14760584.2015.1060860","article-title":"Universal influenza vaccines, science fiction or soon reality?","volume":"14","author":"de Vries","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1038\/s41385-020-0287-5_bib62","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41385-018-0004-9","article-title":"Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection","volume":"11","author":"Lin","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2017.07.012","article-title":"Ten Strategies of Interferon Evasion by Viruses","volume":"22","author":"Garcia-Sastre","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1038\/s41385-020-0287-5_bib64","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aan8806","article-title":"Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design","volume":"359","author":"Du","year":"2018","journal-title":"Science"},{"key":"10.1038\/s41385-020-0287-5_bib65","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2016.07.023","article-title":"Broadening horizons: new antibodies against influenza","volume":"166","author":"Jackson","year":"2016","journal-title":"Cell"},{"key":"10.1038\/s41385-020-0287-5_bib66","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/QCO.0000000000000496","article-title":"Treatment of influenza with neuraminidase inhibitors","volume":"31","author":"Beard","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/cid\/ciy860","article-title":"Early oseltamivir after hospital admission is associated with shortened hospitalization: a 5-year analysis of oseltamivir timing and clinical outcomes","volume":"69","author":"Katzen","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib68","unstructured":"WHO. Influenza (Seasonal) Ask the Expert: Influenza Q&A. 2018 06 Nov 2018 [cited 28 Oct 2019] https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"10.1038\/s41385-020-0287-5_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","volume":"203","author":"Hayden","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"Suppl 2","key":"10.1038\/s41385-020-0287-5_bib70","first-page":"ii5","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 1","key":"10.1038\/s41385-020-0287-5_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/irv.12045","article-title":"Newer influenza antivirals, biotherapeutics and combinations","volume":"7","author":"Hayden","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1038\/s41385-020-0287-5_bib72","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1038\/s41385-020-0287-5_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/infdis\/jis727","article-title":"The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009\u20132010 influenza A virus subtype H1N1 pandemic","volume":"207","author":"Aoki","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib74","unstructured":"PHE. Influenza: treatment and prophylaxis using anti-viral agents. 2019 [cited 29 Oct 2019] https:\/\/www.gov.uk\/government\/publications\/influenza-treatment-and-prophylaxis-using-anti-viral-agents."},{"key":"10.1038\/s41385-020-0287-5_bib75","unstructured":"CDC. Influenza Antiviral Medications. 2019 [cited 29 Oct 2019] https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/index.htm."},{"key":"10.1038\/s41385-020-0287-5_bib76","doi-asserted-by":"crossref","first-page":"ofw023","DOI":"10.1093\/ofid\/ofw023","article-title":"Relationship between upper respiratory tract influenza test result and clinical outcomes among critically Ill influenza patients","volume":"3","author":"Reddy","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib77","unstructured":"Jefferson, T. et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database System. Rev. CD008965 (2014)."},{"key":"10.1038\/s41385-020-0287-5_bib78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/cid\/cir400","article-title":"Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials","volume":"53","author":"Hern\u00e1n","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir. Med"},{"key":"10.1038\/s41385-020-0287-5_bib80","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib81","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat. Med"},{"key":"10.1038\/s41385-020-0287-5_bib82","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"10.1038\/s41385-020-0287-5_bib83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1756283X10366368","article-title":"Anti-tumor necrosis factor therapy and influenza: keeping it in perspective","volume":"3","author":"Shale","year":"2010","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1038\/s41385-020-0287-5_bib84","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L","article-title":"Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology","volume":"31","author":"Hussell","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1038\/s41385-020-0287-5_bib85","first-page":"159","article-title":"Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains","volume":"3","author":"Bermejo-Martin","year":"2009","journal-title":"J. Infect. Developing Ctries."},{"key":"10.1038\/s41385-020-0287-5_bib86","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.chest.2016.11.012","article-title":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza a(h3n2) infection: an open-label randomized, controlled, phase IIb\/III trial","volume":"151","author":"Hung","year":"2017","journal-title":"Chest"},{"key":"10.1038\/s41385-020-0287-5_bib87","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/cid\/ciw174","article-title":"Statin use and hospital length of stay among adults hospitalized with community-acquired pneumonia","volume":"62","author":"Havers","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib88","doi-asserted-by":"crossref","first-page":"ofv028","DOI":"10.1093\/ofid\/ofv028","article-title":"Statin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations","volume":"2","author":"Laidler","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1038\/s41385-020-0287-5_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0764-5","article-title":"Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis","volume":"19","author":"Zhang","year":"2015","journal-title":"Crit. Care"},{"key":"10.1038\/s41385-020-0287-5_bib90","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","article-title":"Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores","volume":"183","author":"Kim","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41385-020-0287-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-020-0287-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922003233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021922003233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41385-020-0287-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:12:55Z","timestamp":1761829975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021922003233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1933021922003233"],"URL":"https:\/\/doi.org\/10.1038\/s41385-020-0287-5","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seasonal and pandemic influenza: 100 years of progress, still much to learn","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41385-020-0287-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/s41385-020-0291-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 \u00a9 Society for Mucosal Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}